| 发明名称 | Antiviral compounds | ||
| 摘要 | The invention is related to anti-viral compounds, compositions containing such compounds, and therapeutic methods that include the administration of such compounds, as well as to processes and intermediates useful for preparing such compounds. | ||
| 申请公布号 | US9511056(B2) | 申请公布日期 | 2016.12.06 |
| 申请号 | US201414280478 | 申请日期 | 2014.05.16 |
| 申请人 | Gilead Pharmasset LLC | 发明人 | Bacon Elizabeth M.;Canales Eda;Cho Aesop;Cottell Jeromy J.;Desai Manoj C.;Graupe Michael;Guo Hongyan;Halcomb Randall L.;Kato Darryl;Kim Choung U.;Kirschberg Thorsten A.;Krygowski Evan S.;Lazerwith Scott E.;Link John O.;Liu Hongtao;Liu Qi;Mackman Richard L.;Mitchell Michael L.;Parrish Jay P.;Pyun Hyung-Jung;Saugier Joseph H.;Schroeder Scott D.;Sun Jianyu;Taylor James G.;Trenkle James D.;Tse Winston C.;Vivian Randall W.;Watkins William J.;Xu Lianhong |
| 分类号 | C07D403/04;C07D403/14;C07D471/08;A61K45/06;A61K31/4184;C07F5/02 | 主分类号 | C07D403/04 |
| 代理机构 | Sheppard Mullin Richter & Hampton LLP | 代理人 | Sheppard Mullin Richter & Hampton LLP |
| 主权项 | 1. A method of eliminating hepatitis C virus in a human patient in need thereof comprising administering to said human an effective amount of: (1) a compound of formula:and (2) a NS5B polymerase inhibitor. | ||
| 地址 | Foster City CA US | ||